You are here

  • Home
  • Online First
  • Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis

Article info

Article menu

other Versions

Download PDFPDF
Original research
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis

Authors

  • Bich Doan Nguyen-Sträuli University Hospital Zurich, Department of Gynecology, Zurich, ZH, SwitzerlandYoung Academy of Gynecologic Oncology (JAGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Joanna Baum Young Academy of Gynecologic Oncology (JAGO), Berlin, GermanyDepartment of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Philipp Meyer-Wilmes Young Academy of Gynecologic Oncology (JAGO), Berlin, GermanyUniversity Hospital Aachen, Department of Gynaecology and Obstetrics, Aachen, Nordrhein-Westfalen, Germany PubMed articlesGoogle scholar articles
  • Anne Kreklau Young Academy of Gynecologic Oncology (JAGO), Berlin, GermanyUniversity Hospital Leipzig, Department of Obstetrics and Gynaecology, Leipzig, Sachsen, Germany PubMed articlesGoogle scholar articles
  • Christina Buschmann Young Academy of Gynecologic Oncology (JAGO), Berlin, GermanyUniversity Hospital Munich, Department of Gynecology and Obstetrics, Grosshadern Campus, Munchen, Bayern, Germany PubMed articlesGoogle scholar articles
  • Nabila El Ouardi Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany PubMed articlesGoogle scholar articles
  • Christina Fotopoulou Department of Gynaecologic Oncology, Imperial College London, Faculty of Medicine, London, London, UK PubMed articlesGoogle scholar articles
  • Michael Hummel Charite Universitatsmedizin Berlin, Institut für Pathologie, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Radoslav Chekerov Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Elena Braicu Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jalid Sehouli Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Klaus Pietzner Young Academy of Gynecologic Oncology (JAGO), Berlin, GermanyDepartment of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr. Bich Doan Nguyen-Sträuli, University Hospital Zurich, Department of Gynecology, Zurich, ZH, Switzerland; bichdoan.nguyen{at}usz.ch
View Full Text

Citation

Nguyen-Sträuli BD, Baum J, Meyer-Wilmes P, et al
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis
International Journal of Gynecologic Cancer Published Online First: 27 July 2022. doi: 10.1136/ijgc-2022-003637

Publication history

  • Received April 19, 2022
  • Accepted July 8, 2022
  • First published July 27, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.